<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Seattle Breast Pathology Consultants &#187; invasive carcinoma</title>
	<atom:link href="http://www.breastpathologyconsults.com/blog/tag/invasive-carcinoma/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.breastpathologyconsults.com/blog</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Thu, 05 Aug 2010 17:13:44 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Can Breast Cancer Be Diagnosed On a Bone Marrow Biopsy?</title>
		<link>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/can-breast-cancer-be-diagnosed-on-a-bone-marrow-biopsy/</link>
		<comments>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/can-breast-cancer-be-diagnosed-on-a-bone-marrow-biopsy/#comments</comments>
		<pubDate>Thu, 05 Aug 2010 17:13:44 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Ask the Pathologist]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[immunohistochemistry]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=698</guid>
		<description><![CDATA[Question: My 75 y/o mother who was sent to an oncologist due to a bone scan that showed a hot spot on the right rib. A bone marrow biopsy/aspir was done and she was diagnosed with breast cancer with mets to the spine-results were ER/PR +.  Mammograms, cat scans, Petscans were neg.  She [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/can-breast-cancer-be-diagnosed-on-a-bone-marrow-biopsy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Estrogen Receptor Staining in Breast Cancer</title>
		<link>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/estrogen-receptor-staining-in-breast-cancer/</link>
		<comments>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/estrogen-receptor-staining-in-breast-cancer/#comments</comments>
		<pubDate>Tue, 29 Jun 2010 00:23:55 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Ask the Pathologist]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[ductal carcinoma in situ]]></category>
		<category><![CDATA[estrogen receptor]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=681</guid>
		<description><![CDATA[Question: I recently had a breast biopsy with invasive ductal carcinoma, grade 3 and ductal carcinoma in situ.  My report said &#8220;the carcinoma is estrogen and progesterone receptor negative (&#60;5%) and negative for her2/neu over-expression (1+).&#8221;  I read online that sometimes even less than 5% could still be positive for the estrogen receptor. [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/estrogen-receptor-staining-in-breast-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Focal ADH on Core Biopsy</title>
		<link>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/663/</link>
		<comments>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/663/#comments</comments>
		<pubDate>Sun, 18 Apr 2010 19:21:49 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Ask the Pathologist]]></category>
		<category><![CDATA[atypical ductal hyperplasia]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[carcinoma in situ]]></category>
		<category><![CDATA[core biopsy]]></category>
		<category><![CDATA[ductal carcinoma in situ]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>
		<category><![CDATA[second opinion]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=663</guid>
		<description><![CDATA[Question:  Hello, I just received the results of my core biopsy, I would like you opinion on it. Proliferated fibrocystic changes comprised of ductal epithelial hyerlasia with focal atypia, duct single minute microcalcification seen in benign fibrotic tissue. Patient needs surgery consult for breast biopsy. At this point, what do you think my risk is for cancer? I [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/663/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Atypical Ductal Hyperplasia and Core Biopsy</title>
		<link>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/atypical-ductal-hyperplasia-and-core-biopsy/</link>
		<comments>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/atypical-ductal-hyperplasia-and-core-biopsy/#comments</comments>
		<pubDate>Fri, 26 Mar 2010 16:57:17 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Ask the Pathologist]]></category>
		<category><![CDATA[atypical ductal hyperplasia]]></category>
		<category><![CDATA[carcinoma in situ]]></category>
		<category><![CDATA[core biopsy]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=659</guid>
		<description><![CDATA[Question: After several years of mammograms showing mild calcifications, this year I was informed that the radiologist saw some mild changes in the calcifications.  I did another mammogram, followed by a core biopsy.  The initial report came back benign, but the final came back as atypical ductal hyperplasia.  I am now scheduled [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/atypical-ductal-hyperplasia-and-core-biopsy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Understanding Your Breast Cancer Stage</title>
		<link>http://www.breastpathologyconsults.com/blog/sbpc_library/understanding-your-breast-cancer-stage/</link>
		<comments>http://www.breastpathologyconsults.com/blog/sbpc_library/understanding-your-breast-cancer-stage/#comments</comments>
		<pubDate>Sun, 17 Jan 2010 21:46:40 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[SBPC Library]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[breast cancer stage]]></category>
		<category><![CDATA[carcinoma in situ]]></category>
		<category><![CDATA[invasive carcinoma]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=29</guid>
		<description><![CDATA[Knowing the stage of your breast cancer helps your medical team determine how big the cancer is and if it has spread. This helps them guide your therapy and provide reliable prognostic information.
In general, staging is done following your surgery, either after lumpectomy or mastectomy. It usually includes evaluation of the lymph nodes in your [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/sbpc_library/understanding-your-breast-cancer-stage/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Will Molecular Testing Make Grading Breast Cancer Obsolete?</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/will-molecular-testing-make-grading-breast-cancer-obsolete/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/will-molecular-testing-make-grading-breast-cancer-obsolete/#comments</comments>
		<pubDate>Thu, 14 Jan 2010 02:35:58 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=540</guid>
		<description><![CDATA[This past October I was at the XXVII Brazilian Society of Pathology meeting in Buzios, Brazil where I was invited to give a few lectures on breast pathology.  I gave one lecture on the traditional grading of breast cancer vs. the new molecular tests that are available. The audience response made me think more on [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/will-molecular-testing-make-grading-breast-cancer-obsolete/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Research Supporting the Favorable Prognosis of Tubular Carcinoma</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-supporting-the-favorable-prognosis-of-tubular-carcinoma/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-supporting-the-favorable-prognosis-of-tubular-carcinoma/#comments</comments>
		<pubDate>Thu, 07 Jan 2010 03:33:17 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[invasive ductal carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=532</guid>
		<description><![CDATA[In the January 1, 2010 issue of the Journal of Clinical Oncology, a study was released which confirms the belief that tubular carcinomas of the breast have a more favorable prognosis than typical Grade I invasive carcinomas, NST.
I&#8217;ve reported before on invasive carcinomas which have been associated with a more favorable prognosis.  Tubular carcinoma is [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/new-research-supporting-the-favorable-prognosis-of-tubular-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Equivocal HER2 Results</title>
		<link>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/equivocal-her2-results/</link>
		<comments>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/equivocal-her2-results/#comments</comments>
		<pubDate>Wed, 19 Nov 2008 18:13:48 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Ask the Pathologist]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[immunohistochemistry]]></category>
		<category><![CDATA[invasive carcinoma]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=474</guid>
		<description><![CDATA[Question: I am in the Uk and my wife (42) has Grade 2 breast cancer 2 nodes er+ and pr + my question is about her path report: the HER2 was registered at 2.2 after the FISH test &#8211; does this mean that herceptin will work or is it to borderline to benefit? As the [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/equivocal-her2-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Changes Between Core Biopsy and Surgery</title>
		<link>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/changes-between-core-biopsy-and-surgery/</link>
		<comments>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/changes-between-core-biopsy-and-surgery/#comments</comments>
		<pubDate>Sat, 15 Nov 2008 16:24:39 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Ask the Pathologist]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=472</guid>
		<description><![CDATA[Question: I have been diagnosed with invasive ductal carcinoma. The biopsy results said the tumor was ER and PR positive, and HER2 negative, and a grade 2. However, after surgery, the pathology report said ER positive, PR negative, and didn&#8217;t mention the HER2 status at all. It also changed the grade down to a 1. [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/changes-between-core-biopsy-and-surgery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sarcomatoid Carcinoma</title>
		<link>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/sarcomatoid-carcinoma/</link>
		<comments>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/sarcomatoid-carcinoma/#comments</comments>
		<pubDate>Tue, 04 Nov 2008 21:59:23 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Ask the Pathologist]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[metaplastic carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=467</guid>
		<description><![CDATA[Question: What is a sarcomatoid carcinoma? My core biopsy report said &#8220;invasive carcinoma with spindle cell features, cannot rule out sarcomatoid carcinoma.&#8221;

Answer: Sarcomatoid carcinoma is a type of metaplastic carcinoma. These are invasive carcinomas of the breast but they just look different under the microscope than the usual type of invasive carcinoma, NST. The pathologist [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/sarcomatoid-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Could LCIS Be a Real Cancer and Not Just a Marker of Increased Risk?</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/could-lcis-be-a-real-cancer-and-not-just-a-marker-of-increased-risk/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/could-lcis-be-a-real-cancer-and-not-just-a-marker-of-increased-risk/#comments</comments>
		<pubDate>Thu, 30 Oct 2008 17:33:20 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[carcinoma in situ]]></category>
		<category><![CDATA[ductal carcinoma in situ]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[lobular carcinoma in situ]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=465</guid>
		<description><![CDATA[I&#8217;ve written before about the controversy over lobular carcinoma in situ (LCIS) and whether it is just a marker of increased risk or possibly a precursor to invasive carcinoma, like ductal carcinoma in situ (DCIS). The reason it was felt to be just a marker of increased risk was that most early studies showed that [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/could-lcis-be-a-real-cancer-and-not-just-a-marker-of-increased-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Androgen Receptors and Breast Cancer: A New Therapeutic Target?</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/androgen-receptors-and-breast-cancer-a-new-therapeutic-target/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/androgen-receptors-and-breast-cancer-a-new-therapeutic-target/#comments</comments>
		<pubDate>Fri, 24 Oct 2008 17:21:20 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[estrogen receptor]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[triple negative]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=449</guid>
		<description><![CDATA[Everyone has heard of the importance of estrogen and progesterone receptors in breast cancer&#8211;but how many of you have heard of the possible role of androgen receptors (AR) in breast cancer?
I have a particular interest in this subject as we published an article several years ago that found AR positivity in 49% of estrogen receptor [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/androgen-receptors-and-breast-cancer-a-new-therapeutic-target/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Multifocal Breast Cancer and Staging</title>
		<link>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/multifocal-breast-cancer-and-staging/</link>
		<comments>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/multifocal-breast-cancer-and-staging/#comments</comments>
		<pubDate>Thu, 23 Oct 2008 22:38:30 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Ask the Pathologist]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[breast cancer stage]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[pathologist]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=444</guid>
		<description><![CDATA[Question: My lumpectomy report says: Invasive ductal carcinoma, two foci, 2.4 cm, combined histologic grade II/III, margins widely free (&#62;5mm), see comment. The comment says there were two tumors, one 1.3 cm and one 0.6 cm, total span 2.4 cm.  My question is&#8211;my doctor has staged me as IIA (my nodes were negative)&#8211;but my [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/ask_the_pathologist/multifocal-breast-cancer-and-staging/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MRI and Partial Breast Irradiation (PBI): New Research</title>
		<link>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/mri-and-partial-breast-irradiation-pbi-new-research/</link>
		<comments>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/mri-and-partial-breast-irradiation-pbi-new-research/#comments</comments>
		<pubDate>Wed, 22 Oct 2008 18:26:30 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[Dr. Lawton's Blog]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[invasive carcinoma]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=434</guid>
		<description><![CDATA[A study to be released in the November 1 issue of the journal Cancer took a retrospective look at 110 patients with invasive cancer who were involved in a clinical trial on the use of partial breast irradiation (PBI) vs. whole breast irradiation.
MRIs were performed on the patients and the study found that in 10% [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/dr_lawtons_blog/mri-and-partial-breast-irradiation-pbi-new-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What Your Core Needle Biopsy Diagnosis Means</title>
		<link>http://www.breastpathologyconsults.com/blog/sbpc_library/what-your-core-needle-biopsy-diagnosis-means/</link>
		<comments>http://www.breastpathologyconsults.com/blog/sbpc_library/what-your-core-needle-biopsy-diagnosis-means/#comments</comments>
		<pubDate>Wed, 15 Oct 2008 18:16:42 +0000</pubDate>
		<dc:creator>drlawton</dc:creator>
				<category><![CDATA[SBPC Library]]></category>
		<category><![CDATA[atypical ductal hyperplasia]]></category>
		<category><![CDATA[atypical lobular hyperplasia]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[carcinoma in situ]]></category>
		<category><![CDATA[core biopsy]]></category>
		<category><![CDATA[fibroadenoma]]></category>
		<category><![CDATA[flat epithelial atypia]]></category>
		<category><![CDATA[invasive carcinoma]]></category>
		<category><![CDATA[papilloma]]></category>

		<guid isPermaLink="false">http://www.breastpathologyconsults.com/blog/?p=401</guid>
		<description><![CDATA[In the past decade, core needle biopsy has taken over fine needle aspiration (FNA) as the main tool for diagnosing image-detected or palpable breast lesions. While this biopsy technique is just a sample, cores of breast tissue are removed vs. individual cells as in FNA and thus the pathologist has more information to make an [...]]]></description>
		<wfw:commentRss>http://www.breastpathologyconsults.com/blog/sbpc_library/what-your-core-needle-biopsy-diagnosis-means/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
